Literature DB >> 16508165

KmrA multidrug efflux pump from Klebsiella pneumoniae.

Wakano Ogawa1, Motohiro Koterasawa, Teruo Kuroda, Tomofusa Tsuchiya.   

Abstract

We cloned a gene responsible for multidrug resistance from the chromosomal DNA of Klebsiella pneumoniae MGH78578 that showed multidrug resistance. We designated the gene kmrA. The deduced amino acid sequence of KmrA was similar to that of SmvA that is responsible for methyl viologen-resistance in Salmonella enterica sv. Typhi and Typhimurium. Introduction of the cloned kmrA gene into drug-hypersensitive Escherichia coli KAM32 cells made them resistant to acriflavine, 4',6-diamidino-2-phenylindole (DAPI), Hoechst 33342, tetraphenylphosphonium chloride (TPPCl), methyl viologen and ethidium bromide. We observed elevated energy-dependent efflux of ethidium in E. coli cells carrying the kmrA gene compared with control cells. We also cloned the smvA gene from S. enterica sv. Typhimurium LT2 and investigated the resistance pattern for several drugs. The pattern was similar between KmrA from K. pneumoniae and SmvA from S. enterica.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16508165     DOI: 10.1248/bpb.29.550

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  13 in total

Review 1.  A balancing act: efflux/influx in mycobacterial drug resistance.

Authors:  G E Louw; R M Warren; N C Gey van Pittius; C R E McEvoy; P D Van Helden; T C Victor
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

Review 2.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

Review 3.  The Great ESKAPE: Exploring the Crossroads of Bile and Antibiotic Resistance in Bacterial Pathogens.

Authors:  Kevin S Gipson; Kourtney P Nickerson; Eliana Drenkard; Alejandro Llanos-Chea; Snaha Krishna Dogiparthi; Bernard B Lanter; Rhianna M Hibbler; Lael M Yonker; Bryan P Hurley; Christina S Faherty
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

4.  Ionic Liquids Impact the Bioenergy Feedstock-Degrading Microbiome and Transcription of Enzymes Relevant to Polysaccharide Hydrolysis.

Authors:  Yu-Wei Wu; Brendan Higgins; Chaowei Yu; Amitha P Reddy; Shannon Ceballos; Lawrence D Joh; Blake A Simmons; Steven W Singer; Jean S VanderGheynst
Journal:  mSystems       Date:  2016-12-13       Impact factor: 6.496

5.  KpnEF, a new member of the Klebsiella pneumoniae cell envelope stress response regulon, is an SMR-type efflux pump involved in broad-spectrum antimicrobial resistance.

Authors:  Vijaya Bharathi Srinivasan; Govindan Rajamohan
Journal:  Antimicrob Agents Chemother       Date:  2013-07-08       Impact factor: 5.191

6.  Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence.

Authors:  Emma Padilla; Enrique Llobet; Antonio Doménech-Sánchez; Luis Martínez-Martínez; José Antonio Bengoechea; Sebastián Albertí
Journal:  Antimicrob Agents Chemother       Date:  2009-10-26       Impact factor: 5.191

7.  A tripartite efflux pump involved in gastrointestinal colonization by Klebsiella pneumoniae confers a tolerance response to inorganic acid.

Authors:  Sophie Coudeyras; Laurence Nakusi; Nicolas Charbonnel; Christiane Forestier
Journal:  Infect Immun       Date:  2008-07-21       Impact factor: 3.441

Review 8.  Mechanism of action of and resistance to quinolones.

Authors:  Anna Fàbrega; Sergi Madurga; Ernest Giralt; Jordi Vila
Journal:  Microb Biotechnol       Date:  2008-10-13       Impact factor: 5.813

9.  Modulation of Bacterial Multidrug Resistance Efflux Pumps of the Major Facilitator Superfamily.

Authors:  Sanath Kumar; Mun Mun Mukherjee; Manuel F Varela
Journal:  Int J Bacteriol       Date:  2013

10.  Role of novel multidrug efflux pump involved in drug resistance in Klebsiella pneumoniae.

Authors:  Vijaya Bharathi Srinivasan; Bharat Bhushan Singh; Nitesh Priyadarshi; Neeraj Kumar Chauhan; Govindan Rajamohan
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.